Logo
Login

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
ASSETS
Current assets:
Cash and cash equivalents
Total cash and cash equivalents
Accounts receivable, net
Total accounts receivable, net
Prepaid expenses
Other current assets
Total current assets
Notes receivable, net
Property, equipment, and software, net
Total property, equipment, and software, net
Right-of-use-assets, net
Other assets
Total other assets
Total assets
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities
Current liabilities:
Accounts payable
Total accounts payable
Accrued expenses and other current liabilities
Total accrued expenses and other current liabilities
Current portion of lease liabilities
Total current liabilities
Lease liabilities, net of current portion
Other non-current liabilities
Total other non-current liabilities
Total liabilities
Stockholders' equity:
Common stock
Common Class A
Common Class B
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total accumulated other comprehensive loss
Total stockholders' equity attributable to Enfusion, Inc.
Non-controlling interests
Total stockholders' equity
Total liabilities and stockholders' equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans